DIMITRIOS LAURIN WAGNER to T-Lymphocytes
This is a "connection" page, showing publications DIMITRIOS LAURIN WAGNER has written about T-Lymphocytes.
Connection Strength
1.911
-
Splendid isolation. Blood. 2023 06 01; 141(22):2665-2666.
Score: 0.423
-
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019 02; 25(2):242-248.
Score: 0.308
-
Promises and potential pitfalls of in vivo CAR gene therapy. Blood. 2026 Jul 30; 148(5):535-544.
Score: 0.132
-
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphoma. J Immunother Cancer. 2025 Apr 09; 13(4).
Score: 0.120
-
CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products. Blood Adv. 2023 08 08; 7(15):4124-4134.
Score: 0.107
-
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells. Genome Biol. 2023 04 24; 24(1):89.
Score: 0.105
-
The uncut version: base-edited allo-CAR T cells. Blood. 2022 08 11; 140(6):526-527.
Score: 0.100
-
Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing. Front Immunol. 2022; 13:865424.
Score: 0.099
-
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients. Mol Ther. 2021 01 06; 29(1):32-46.
Score: 0.088
-
Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells. Mol Carcinog. 2020 07; 59(7):724-735.
Score: 0.085
-
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.
Score: 0.085
-
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discov. 2017 11; 7(11):1238-1247.
Score: 0.071
-
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296.
Score: 0.070
-
Lung tumouroids as a testing platform for precision CAR T cell therapy. Nat Biomed Eng. 2026 Apr; 10(4):815-831.
Score: 0.032
-
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors. Nat Commun. 2025 Dec 09; 16(1):10987.
Score: 0.032
-
Integration of ?-deficient CARs into the CD3? gene conveys potent cytotoxicity in T and NK cells. Blood. 2024 06 20; 143(25):2599-2611.
Score: 0.028
-
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. Nat Rev Clin Oncol. 2023 01; 20(1):49-62.
Score: 0.026